Scientists react to a conference abstract about eliminating HIV in cell culture using CRISPR-Cas that is being presented at the … read more
The National Institute for Health and Care Excellence (NICE) has published a draft guidance recommending cabotegravir with rilpivirine, the first … read more
The findings, presented at the International AIDS Society conference (and currently not available as a study), report that, after treatment … read more
Research, published in the journal Lancet HIV, reports that a second patient has been cured of HIV. Dr Jonathan Stoye, … read more
Researchers, publishing in Nature Medicine, reported that being homozygous for a protective mutation against HIV is associated with increased mortality … read more
Reactions to claims that a second HIV-1 patient is in remission as published in Nature. Prof Sarah Fidler, Professor of … read more
A new study, published in PLOS Pathogens, investigates the genome editing of bone-morrow stem cells in pigtail macaques as a potential treatment for simian/human immunodeficiency virus (SHIV).
A new study, published in the Annals of Oncology, shows a drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer. read more
Researchers publishing in the journal Nature have reported the findings of a first-in-man trial of an antibody treatment for use against HIV, stating that it is safe and effective in reducing HIV-1 pathology and suggesting that be explored for treatment of the disease. read more
The Chief Medical Officer Professor Dame Sally Davies came to the SMC to brief journalist on plans to update HIV regulations. read more
New global guidelines from World Health Organization (WHO) on when to start taking antiretroviral therapy (ART) for HIV could avert an additional 3 million deaths and prevent 4 million new infections between now and 2025. read more
Virologist Dr Deborah Persaud presented evidence that a baby girl in the US appeared to have been cured of HIV, after very early treatment with standard drug therapy, at the Conference on Retroviruses and Opportunistic Infections in Atlanta. read more
This briefing was run in collaboration with WHO Europe to update journalists on the latest surveillance figures for HIV/AIDS in Europe ahead of World AIDS Day 2011. read more
A Nature paper outlined a new technique that uses gene delivery to produce neutralising antibodies against HIV. read more
Researchers briefed journalists on the first clinical trial involving a monoclonal antibody produced from genetically modified plants, designed for use as a topical microbicide preventing HIV transmission between sexual partners. read more
Promising new developments in the field of HIV vaccine development. read more
A trial carried out in Thailand found that a combination of two vaccines lowered the risk of contracting HIV by 31.2%. This is the first significant evidence for a preventative vaccine for HIV, though experts remained cautious over the results’ interpretation. read more
The research shows that a common chemical, when applied in gel form, can prevent the sread of SIV, the equivalent of HIV in monkeys. read more
The US trial of a potentially promising new vaccine for HIV ended in failure when it was found to offer no protection against the virus. read more
This year’s prize was awarded to Harald zur Hausen for his discovery of the human papilloma virus, and to Françoise Barré-Sinoussi and Luc Montagnier for their discovery of HIV. read more
